Suchergebnisse - "Antibodies, Monoclonal, Humanized"

PubPharm (5.352)

41

Toxic Cardiomyopathy in a Young Patient Treated for Her2-Positive Early Breast Cancer : Case Report and Literature Review

enthalten in: Acta medica academica | 2023

von Hadžibeganović, A. | Koprić, D.

42

Macrolide and Ketolide Antibiotics Inhibit the Cytotoxic Effect of Trastuzumab Emtansine in HER2-Positive Breast Cancer Cells : Implication of a Potential Drug-ADC Interaction in Cancer Chemotherapy

enthalten in: Molecular pharmaceutics | 2023

von Kiyomiya, K. | Tomabechi, R. | Saito, N. | +6

43

In Vivo and In Vitro Efficacy of Trastuzumab Deruxtecan in Uterine Serous Carcinoma

enthalten in: Molecular cancer therapeutics | 2023

von Mutlu, L. | Manavella, D. | Bellone, S. | +19

44

Trastuzumab Deruxtecan : A Review in Gastric or Gastro-Oesophageal Junction Adenocarcinoma

enthalten in: Targeted oncology | 2023

von Kang, C.

45

Twenty-Year Follow-Up of a Phase II Trial of Taxotere/Carboplatin/Herceptin in Patients With Metastatic HER2-Positive Breast Cancer

enthalten in: The oncologist | 2023

von Gomez Marti, J. | Nasrazadani, A. | Ding, Y. | +2

46

Empower the Potential of Trastuzumab Deruxtecan with Novel Combinations

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Rolfo, C. | Del Re, M. | Russo, A.

CommentOn: Clin Cancer Res. 2023 Nov 1;29(21):4385-4398. - PMID 37279095

47

Pyrotinib versus placebo in combination with trastuzumab and docetaxel as first line treatment in patients with HER2 positive metastatic breast cancer (PHILA) : randomised, double blind, multicentre, phase 3 trial

enthalten in: BMJ (Clinical research ed.) | 2023

von Ma, F. | Yan, M. | Li, W. | +28

ErratumIn: BMJ. 2023 Nov 16;383:p2665. - PMID 37973164

48

Evaluation of HER-2 positive breast cancer treated with dual-targeted treatment of trastuzumab plus pertuzumab

enthalten in: Immunopharmacology and immunotoxicology | 2023

von Jiang, S. | Geng, S. | Gao, X. | +5

ErratumIn: Immunopharmacol Immunotoxicol. 2023 Mar 27;:1. - PMID 36972201

49

Newly Approved and Emerging Agents in HER2-Positive Metastatic Breast Cancer

enthalten in: Clinical breast cancer | 2023

von Graff, S. | Yan, F. | Abdou, Y.

50

Immuno-PET Detects Antibody-Drug Potency on Coadministration with Statins

enthalten in: Journal of nuclear medicine : official publication, Society of Nuclear Medicine | 2023

von Brown, E. | Shmuel, S. | Mandleywala, K. | +6